• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: a case-control study and in sili

tetano

Editor, Senior Moderator
J Med Virol


. 2021 Nov 25.
doi: 10.1002/jmv.27477. Online ahead of print.
Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: a case-control study and in silico analyses


Milad Heidari Nia[SUP] 1 [/SUP], Mohsen Rokni[SUP] 2 [/SUP], Shekoufeh Mirinejad[SUP] 1 [/SUP], Maryam Kargar[SUP] 3 [/SUP], Sara Rahdar[SUP] 1 [/SUP], Saman Sargazi[SUP] 1 [/SUP], Mohammad Sarhadi[SUP] 1 [/SUP], Ramin Saravani[SUP] 1 4 [/SUP]



Affiliations

Abstract

As the present coronavirus disease 2019 (COVID-19) spreads and existing data suggested susceptibility factors for developing a severe course of the disease. This case-control experiment aimed to study the associations of genetic polymorphisms in tumor necrosis factors (TNFs) with COVID-19 and its mortality rate. A total of 550 participants (275 subjects and 275 controls) were enrolled. The tetra-ARMS-PCR technique was recruited to detect -308G>A TNFα and +252A>G TNFβ polymorphisms among the Iranian population. We demonstrated that participants carrying the G allele of TNFβ-252A/G, rs909253 A>G was more frequent in COVID-19 subjects compared to the healthy group and statistically increased the disease risk (OR=1.55, 95% CI=1.23-1.96, P<0.0001). At the same time, the A allele of TNFα-311A/G, rs1800629 G>A moderately decreased the risk of COVID-19 (OR=0.68, 95% CI=0.53-0.86, P<0.002). Also, we analyzed the various genotypes regarding the para-clinical and disorder severity; we found that the AA genotype of TNFβ-252A/G, rs909253 A>G, the CT scan pattern was different in comparison to cases in the AG genotype with P [SUB]1[/SUB] <0.001. In addition, in the severe cases of COVID-19, leucocyte and neutrophil count and duration of ICU hospitalization in the death group have been significantly increased (P<0.001). Moreover, the TNFα-311A/G, rs1800629 G>A variant is likely to change the pattern of splicing factor sites. Our findings provided deep insights into the relationship between TNFα/TNFβ polymorphisms and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Replicated studies may give scientific evidence for exploring molecular mechanisms of COVID-19 in other ethnicities. This article is protected by copyright. All rights reserved.

Keywords: ARDS; COVID-19; CT pattern; Polymorphism; SARS-CoV-2; Tumor necrosis factor.
 
Back
Top Bottom